SLC40A1 and breast cancer: Overexpressed in esophageal adenocarcinoma compared with normal (49). Expression was lower in prostate and breast cancers compared to normal and declined with increasing tumor grade (71–73). Low ferroportin expression levels in pancreatic cancer tissue were significantly associated with poor prognosis (74).